Paper26344625
Identifying the Conditions Under Which Antibodies Protect Against Infection by Equine Infectious Anemia Virus.
Schwartz EJ and 1 other. Vaccines (Basel), 2014. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Identifying the Conditions Under Which Antibodies Protect Against Infection by Equine Infectious Anemia Virus. Papers, record 26344625. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26344625
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Identifying the Conditions Under Which Antibodies Protect Against Infection by Equine Infectious Anemia Virus.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15838802 | Predicting the potential individual- and population-level effects of imperfect herpes simplex virus type 2 vaccines. | J Infect Dis | 2005 | https://conductscience.org/library/papers/15838802 | PubMed |
| 2 | 9143283 | Control of equine infectious anemia virus is not dependent on ADCC mediating antibodies. | Virology | 1997 | https://conductscience.org/library/papers/9143283 | PubMed |
| 3 | 24252283 | Understanding virus-host dynamics following EIAV infection in SCID horses. | J Theor Biol | 2014 | https://conductscience.org/library/papers/24252283 | PubMed |
| 4 | 19368787 | Viral load and clinical disease enhancement associated with a lentivirus cytotoxic T lymphocyte vaccine regimen. | Vaccine | 2009 | https://conductscience.org/library/papers/19368787 | PubMed |
| 5 | 21865397 | Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection. | J Virol | 2011 | https://conductscience.org/library/papers/21865397 | PubMed |
| 6 | 14627745 | Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: implications for HIV-1 vaccine development. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/14627745 | PubMed |
| 8 | 21543497 | Protective effects of broadly neutralizing immunoglobulin against homologous and heterologous equine infectious anemia virus infection in horses with severe combined immunodeficiency. | J Virol | 2011 | https://conductscience.org/library/papers/21543497 | PubMed |
| 9 | 20392850 | Selection of a rare neutralization-resistant variant following passive transfer of convalescent immune plasma in equine infectious anemia virus-challenged SCID horses. | J Virol | 2010 | https://conductscience.org/library/papers/20392850 | PubMed |
| 10 | 15236678 | Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us? | Vet Res | 2004 | https://conductscience.org/library/papers/15236678 | PubMed |
| 11 | 10196297 | Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. | J Virol | 1999 | https://conductscience.org/library/papers/10196297 | PubMed |
| 12 | 11683583 | Immune reconstitution prevents continuous equine infectious anemia virus replication in an Arabian foal with severe combined immunodeficiency: lessons for control of lentiviruses. | Clin Immunol | 2001 | https://conductscience.org/library/papers/11683583 | PubMed |
| 13 | 20064271 | Modelling imperfect adherence to HIV induction therapy. | BMC Infect Dis | 2010 | https://conductscience.org/library/papers/20064271 | PubMed |
| 14 | 10577640 | Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis. | Lancet | 1999 | https://conductscience.org/library/papers/10577640 | PubMed |
| 15 | 17392785 | Seasonal dynamics of recurrent epidemics. | Nature | 2007 | https://conductscience.org/library/papers/17392785 | PubMed |
| 16 | 7541846 | Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. | J Virol | 1995 | https://conductscience.org/library/papers/7541846 | PubMed |
| 17 | 15113912 | CD8+-cell-mediated suppression of virulent simian immunodeficiency virus during tenofovir treatment. | J Virol | 2004 | https://conductscience.org/library/papers/15113912 | PubMed |
| 18 | 18842730 | Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. | J Virol | 2008 | https://conductscience.org/library/papers/18842730 | PubMed |
| 19 | 8265611 | Pulse mass measles vaccination across age cohorts. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8265611 | PubMed |
| 20 | 17881889 | Effectiveness and efficiency of imperfect therapeutic HSV-2 vaccines. | Hum Vaccin | 2007 | https://conductscience.org/library/papers/17881889 | PubMed |
| 21 | 2839723 | Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection. | J Virol | 1988 | https://conductscience.org/library/papers/2839723 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36992401 | Key Factors and Parameter Ranges for Immune Control of Equine Infectious Anemia Virus Infection. | Viruses | 2023 | https://conductscience.org/library/papers/36992401 | PubMed |
| 34960718 | Modelling Mutation in Equine Infectious Anemia Virus Infection Suggests a Path to Viral Clearance with Repeated Vaccination. | Viruses | 2021 | https://conductscience.org/library/papers/34960718 | PubMed |
| 27287711 | Characterization of anti-porcine epidemic diarrhea virus neutralizing activity in mammary secretions. | Virus Res | 2016 | https://conductscience.org/library/papers/27287711 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26344625
GET https://conductscience.org/api/papers/v1/26344625/references?page=2